Medical Equipment

Atrial Fibrillation Devices Market Size Outlook and Demand Growth Across 2026–2030

March 10, 2026March 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Atrial Fibrillation Devices Market During 2026–2030?

The atrial fibrillation devices market size has experienced rapid expansion in recent years. It is forecast to grow from $8.6 billion in 2025 to $9.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.7%. The historical increase can be attributed to several factors including the rising prevalence of atrial fibrillation, an expanding geriatric population, the growing burden of cardiovascular disease, the proliferation of electrophysiology labs, and the adoption of implantable cardiac devices.

The atrial fibrillation devices market size is projected to undergo substantial expansion in the coming years, with an expected increase to $14.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period is primarily driven by improvements in ablation technologies, the growing implementation of remote patient monitoring, heightened public understanding of stroke prevention, the proliferation of ambulatory surgical centers, and technological breakthroughs in mapping and navigation systems. Prominent trends anticipated within this period include a greater embrace of catheter ablation procedures, the expanding deployment of wearable and remote ECG monitoring devices, an increasing preference for minimally invasive AFib treatments, the wider application of left atrial appendage closure devices, and a stronger emphasis on early detection and sustained rhythm monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25704&type=smp

Which Economic Or Industry Drivers Are Impacting The Atrial Fibrillation Devices Market?

The escalating prevalence of cardiovascular diseases is set to boost the expansion of the atrial fibrillation device market moving forward. Cardiovascular diseases encompass various disorders impacting the heart and blood vessels, including conditions like heart attacks, strokes, and hypertension. The incidence of these diseases is climbing due to a worldwide increase in obesity and diabetes, coupled with the widespread adoption of sedentary lifestyles and poor dietary habits. Atrial fibrillation (AFib) devices play an essential role in managing cardiovascular diseases by effectively detecting, monitoring, and treating irregular heart rhythms, which are frequently associated with or result from underlying heart conditions. As an illustration, in June 2024, data released by the American Heart Association, a US-based public health organization, indicated that with high blood pressure projected to rise from 51.2% to 61.0%, the number of people diagnosed with cardiovascular diseases is anticipated to increase from 128 million in 2020 to more than 184 million by 2050. This surge in cardiovascular diseases is consequently driving the growth of the atrial fibrillation device market.

How Are The Various Segments Of The Atrial Fibrillation Devices Market Categorized?

The atrial fibrillation devices market covered in this report is segmented –

1) By Device Type: Implantable Devices, External Devices, Catheter-Based Devices

2) By Product: Electrophysiology Ablation Catheters, Cardiac Monitors Or Implantable Loop Recorder, Electrophysiology Diagnostic Catheters, Mapping And Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, Other Products

3) By Technology: Radiofrequency, Cryotherapy, Ultrasound, Other Technologies

4) By Distribution Channel: Direct Sales, Distributors, Online Sales

5) By End-Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Implantable Devices: Implantable Cardioverter Defibrillators, Pacemakers, Insertable Cardiac Monitors

2) By External Devices: External Defibrillators, Holter Monitors, Mobile Cardiac Telemetry Devices, Electrocardiogram Monitors

3) By Catheter-Based Devices: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Mapping and Navigation Systems, Transseptal Access Devices

What Trends Are Affecting The Expansion Of The Atrial Fibrillation Devices Market?

Leading companies operating in the atrial fibrillation devices market are concentrating on technological breakthroughs, such as patient-centric clinical decision support tools, to improve diagnostic precision, customize treatment regimens, and elevate overall patient outcomes. These patient-centric clinical decision support tools represent digital solutions that empower healthcare professionals to tailor treatment choices by analyzing individual patient data. As an illustration, in August 2023, GE HealthCare Technologies Inc., a US-based medical technology company, launched CardioVisio for Atrial Fibrillation. This digital clinical decision support tool is designed to optimize clinician workflows and facilitate precision care for individuals with atrial fibrillation. It enables healthcare providers to visualize the progression of AFib, including past diagnoses, treatments, medications, and associated conditions. The platform also offers guideline-based therapy recommendations, which aids in reducing diagnostic mistakes and streamlining clinical decision-making. CardioVisio consolidates scattered patient information into an accessible format, thereby reducing the workload on medical staff and enabling more prompt, individualized, and effective management of atrial fibrillation.

Which Major Firms Influence Developments In The Atrial Fibrillation Devices Market?

Major companies operating in the atrial fibrillation devices market are Johnson And Johnson Services Inc, Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips NV, Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co Ltd, Japan Lifeline Co Ltd, AliveCor Inc, CardioFocus Inc, Imricor Medical Systems Inc, Kardium Inc, Stereotaxis Inc, Volta Medical, Osypka AG, CathRx Ltd, BIOTRONIK SE And Co KG, EP Solutions SA, CardiacSense Ltd, Biosense Webster Inc, Abbott Electrophysiology, Medtronic Cardiac Rhythm And Heart Failure, Boston Scientific Electrophysiology

Read the full atrial fibrillation devices market report here:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-devices-global-market-report

What Are The Top-Performing Regions Within The Atrial Fibrillation Devices Market?

North America was the largest region in the atrial fibrillation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial fibrillation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Atrial Fibrillation Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25704&type=smp

Browse Through More Reports Similar to the Global Atrial Fibrillation Devices Market 2026, By The Business Research Company

Cardiac Arrhythmia Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Ventricular Fibrillation Market Report 2026

https://www.thebusinessresearchcompany.com/report/ventricular-fibrillation-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795